Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease

被引：9
|
作者：
Ben Nessib, Dorra [1 ,2 ,3 ]
Ferjani, Hanene [1 ,2 ,3 ]
Maatallah, Kaouther [1 ,2 ,3 ]
Rahmouni, Safa [1 ,2 ,3 ]
Kaffel, Dhia [1 ,2 ,3 ]
Hamdi, Wafa [1 ,2 ,3 ]
机构：
[1] Kassab Orthoped Inst, Rheumatol Dept, Mannouba, Tunisia
[2] Univ Tunis el Manar, Fac Med Tunis, Tunis, Tunisia
[3] Res Unit UR17SP04, Tunis 2010, Tunisia
来源：
CLINICAL RHEUMATOLOGY | 2020年 / 39卷 / 12期
关键词：
Inflammatory bowel disease; Spondyloarthritis; Therapeutic; ACTIVE ANKYLOSING-SPONDYLITIS; EVIDENCE-BASED CONSENSUS; MAINTENANCE THERAPY; CROHNS-DISEASE; ULCERATIVE-COLITIS; DOUBLE-BLIND; OPEN-LABEL; PLACEBO; INDUCTION; USTEKINUMAB;
D O I：
10.1007/s10067-020-05136-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Management of spondyloarthritis (SpA) in patients with inflammatory bowel disease (IBD) remains a challenging task that requires multidisciplinary collaboration. Separate guidelines for each disease are well-established. However, the management of SpA co-occurring with Crohn's disease (CD) or ulcerative colitis (UC) has hardly been studied. There are few specific reports that focus on this therapeutic area. The main issue is that some therapeutic options used to treat one disease can negatively influence the other disease course. This study aims to evaluate the therapeutic alternatives that would allow for the appropriate management of patients with both SpA and IBD.
引用
收藏
页码：3543 / 3553
页数：11
相关论文
共 50 条
  • [1] Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease
    Dorra Ben Nessib
    Hanene Ferjani
    Kaouther Maatallah
    Safa Rahmouni
    Dhia Kaffel
    Wafa Hamdi
    [J]. Clinical Rheumatology, 2020, 39 : 3543 - 3553
  • [2] Management of patients with inflammatory bowel disease and spondyloarthritis
    Pouillon, Lieven
    Bossuyt, Peter
    Vanderstukken, Joke
    Moulin, David
    Netter, Patrick
    Danese, Silvio
    Jouzeau, Jean-Yves
    Loeuille, Damien
    Peyrin-Biroulet, Laurent
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (12) : 1363 - 1374
  • [3] Axial spondyloarthritis and inflammatory bowel disease: Therapeutic implications
    Goupille, Philippe
    Vuitton, Lucine
    Wendling, Daniel
    [J]. JOINT BONE SPINE, 2024, 91 (04)
  • [4] Update of the management of inflammatory bowel disease
    Fell, J. M. E.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2012, 97 (01) : 78 - 83
  • [5] Telemedicine in the Management of Inflammatory Bowel Disease: An Update
    Bhattacharya, Sumona
    Wong, Uni
    Cross, Raymond K.
    [J]. SMART HOMECARE TECHNOLOGY AND TELEHEALTH, 2020, 7 : 9 - 17
  • [6] Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance
    Matthew J. Hamilton
    Scott B. Snapper
    Richard S. Blumberg
    [J]. Journal of Gastroenterology, 2012, 47 : 1 - 8
  • [7] Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance
    Hamilton, Matthew J.
    Snapper, Scott B.
    Blumberg, Richard S.
    [J]. JOURNAL OF GASTROENTEROLOGY, 2012, 47 (01) : 1 - 8
  • [8] Update in the management of extraintestinal manifestations of inflammatory bowel disease
    Patil S.A.
    Cross R.K.
    [J]. Current Gastroenterology Reports, 2013, 15 (3)
  • [9] Oral Inflammatory Changes Associated With Inflammatory Bowel Disease in Spondyloarthritis Associated With Early Endoscopic Findings
    Izquierdo Viviana, Parra
    Katherin, Chumacero
    Julio, Alvarado
    Maria, Buenahora
    Monica, Monsalve
    Ana, Torres
    Moreno Lorena, Chila
    Cristian, Florez
    Casallas Alejandro, Ramos
    Juliette, De Avila
    Juan, Bello
    Diego, Jaimes
    Tena Cesar, Pacheco
    Molano Wilson, Bautista
    Consuelo, Romero-Sanchez
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S13 - S13
  • [10] Occult spondyloarthritis in inflammatory bowel disease
    Francesca Bandinelli
    Mirko Manetti
    Lidia Ibba-Manneschi
    [J]. Clinical Rheumatology, 2016, 35 : 281 - 289
12345